Emergent BioSolutions Inc EBS:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/26/21 EST
96.50quote price arrow up+0.50 (+0.52%)
Volume
13,140
Close
96.00quote price arrow down-1.15 (-1.18%)
Volume
535,647
52 week range
46.37 - 137.61

...

Loading . . .

KEY STATS

  • Open97.50
  • Day High98.68
  • Day Low92.86
  • Prev Close97.15
  • 52 Week High137.61
  • 52 Week High Date08/06/20
  • 52 Week Low46.37
  • 52 Week Low Date03/23/20
  • Market Cap5.117B
  • Shares Out53.30M
  • 10 Day Average Volume0.76M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • 1 Year % Change73.54

RATIOS/PROFITABILITY

  • EPS (TTM)5.63
  • P/E (TTM)17.06
  • Fwd P/E (NTM)9.82
  • EBITDA (MRQ)594.60M
  • ROE (MRQ)24.07%
  • Revenue (MRQ)1.555B
  • Gross Margin (MRQ)67.42%
  • Net Margin (MRQ)19.62%
  • Debt To Equity (MRQ)60.46%

EVENTS

  • Earnings Date04/28/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Emergent BioSolutions Inc News

There is no recent news for this security.

Latest EBS News From Our Partners

QUOTE FINDER

Profile

MORE
Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as...
Fuad El-Hibri
Chairman
Robert Kramer Sr.
President
Richard Lindahl
Chief Financial Officer
Adam Havey
Executive Vice President
Atul Saran
Executive Vice President
Address
400 Professional Dr Ste 400
Gaithersburg, MD
20879-3457
United States